Related Experiment Video
Updated: Nov 21, 2025

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease
1Beaumont Research Institute, Department of Neurology, Beaumont Health, Royal Oak, MI, USA.
Understanding Alzheimer's disease (AD) progression is crucial. This review highlights six key factors, including malnutrition and genetic variants, potentially influencing AD decline, suggesting targeted therapies.
Area of Science:
- Neurology
- Gerontology
- Genetics
Background:
- Extensive research exists on Alzheimer's disease (AD) development.
- Factors influencing AD progression remain less understood.
- Identifying progression factors is vital for patient management.
Purpose of the Study:
- To review literature on factors associated with Alzheimer's disease progression.
- To categorize these factors into modifiable, non-modifiable, and clinical groups.
- To identify factors consistently linked to cognitive and neuropathological decline in AD.
Main Methods:
- Literature search on PubMed for factors associated with AD progression.
- Categorization of 15 identified factors into modifiable, non-modifiable, and clinical.
- Analysis of study findings regarding the association of each factor with AD progression.
Main Results:
- Conflicting results were noted for most factors reviewed.
- Six factors showed consistent positive associations with AD progression across studies: malnutrition, genetic variants, altered gene regulation, baseline cognitive level, neuropsychiatric symptoms, and extrapyramidal signs.
- The precise influence of these factors on the rate of AD decline requires further investigation.
Conclusions:
- Several factors, particularly malnutrition, genetic variants, and clinical signs, appear consistently linked to Alzheimer's disease progression.
- Further research is needed to clarify the causal relationship between these factors and the rate of cognitive decline in AD patients.
- Interventions targeting modifiable factors associated with AD progression warrant consideration in therapeutic strategies.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....
Parkinson's Disease: Overview
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Coronary Artery Disease I: Introduction

